Found: 10
Select item for more details and to access through your institution.
Loss of BAP1 function leads to EZH2-dependent transformation.
- Published in:
- Nature Medicine, 2015, v. 21, n. 11, p. 1344, doi. 10.1038/nm.3947
- By:
- Publication type:
- Article
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0111840
- By:
- Publication type:
- Article
Histone Deacetylase 3 Depletion in Osteo/ Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat.
- Published in:
- PLoS ONE, 2010, v. 5, n. 7, p. 1, doi. 10.1371/journal.pone.0011492
- By:
- Publication type:
- Article
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks.
- Published in:
- EMBO Journal, 2008, v. 27, n. 7, p. 1017, doi. 10.1038/emboj.2008.51
- By:
- Publication type:
- Article
Proceedings of the inaugural Dark Genome Symposium: November 2022.
- Published in:
- Mobile DNA, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13100-023-00306-5
- By:
- Publication type:
- Article
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158888
- By:
- Publication type:
- Article
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
- Published in:
- FEBS Letters, 2012, v. 586, n. 19, p. 3448, doi. 10.1016/j.febslet.2012.07.066
- By:
- Publication type:
- Article
The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
- Published in:
- FEBS Letters, 2011, v. 585, n. 19, p. 3011, doi. 10.1016/j.febslet.2011.08.018
- By:
- Publication type:
- Article
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
- Published in:
- Nature Chemical Biology, 2012, v. 8, n. 11, p. 890, doi. 10.1038/nchembio.1084
- By:
- Publication type:
- Article